Literature DB >> 7969162

Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors.

P Auewarakul1, L Gissmann, A Cid-Arregui.   

Abstract

The E6 and E7 early genes of human papillomavirus type 16 have been shown in vitro to play a central role in the transforming capability of this virus. To explore their effects on differentiating epithelial cells in vivo, we used a bovine cytokeratin 10 (K10) promoter to target the expression of E6 and E7 to the suprabasal layers of the epidermis of transgenic mice. In two different lines of mice efficiently expressing the transgene, animals displayed generalized epidermal hyperplasia, hyperkeratosis and parakeratosis in the skin and the forestomach, both known to be sites of K10 expression. Northern (RNA) blot analysis revealed high levels of E6 and E7 transcripts, and in situ hybridizations localized these transcripts to the suprabasal strata of epidermis. In vivo labeling of proliferating cells showed two distinct effects of E6 and E7 expression in the epidermis: (i) an increase in the number of growing cells in the undifferentiated basal layer and (ii) abnormal proliferation of differentiated cells in the suprabasal strata. The expression of c-myc in the skin of transgenics was higher than that in control animals. The induction of c-myc transcription by topical application of tetradecanoyl phorbol acetate was prevented by simultaneous treatment with transforming growth factor beta 1 in nontransgenic skin but not in transgenic skin. In addition, transforming growth factor alpha was found to be overexpressed in the suprabasal layers of the transgenic epidermis. These findings suggest that autocrine mechanisms are involved in the development and maintenance of epidermal hyperplasia. Animals of both lines developed papillomas in skin sites exposed to mechanical irritation and wounding, suggesting that secondary events are necessary for progression to neoplasia. Collectively, these results provide new insights into the tumor promoter activities of human papillomavirus type 16 in epithelial cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969162      PMCID: PMC359364          DOI: 10.1128/mcb.14.12.8250-8258.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

Review 1.  TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights.

Authors:  H L Moses; E Y Yang; J A Pietenpol
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

2.  TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.

Authors:  J A Pietenpol; R W Stein; E Moran; P Yaciuk; R Schlegel; R M Lyons; M R Pittelkow; K Münger; P M Howley; H L Moses
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

Review 3.  The cell biology of transforming growth factor beta.

Authors:  J A Barnard; R M Lyons; H L Moses
Journal:  Biochim Biophys Acta       Date:  1990-06-01

4.  The intermediate filament system of the keratinizing mouse forestomach epithelium: coexpression of keratins of internal squamous epithelia and of epidermal keratins in differentiating cells.

Authors:  J Schweizer; M Rentrop; R Nischt; M Kinjo; H Winter
Journal:  Cell Tissue Res       Date:  1988-07       Impact factor: 5.249

5.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter.

Authors:  B Bailleul; M A Surani; S White; S C Barton; K Brown; M Blessing; J Jorcano; A Balmain
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

7.  Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms.

Authors:  D Smotkin; H Prokoph; F O Wettstein
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

8.  Association of human papillomavirus types 16 and 18 E6 proteins with p53.

Authors:  B A Werness; A J Levine; P M Howley
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

9.  Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation.

Authors:  R Vassar; E Fuchs
Journal:  Genes Dev       Date:  1991-05       Impact factor: 11.361

10.  Rescue of the albino phenotype by introduction of a functional tyrosinase gene into mice.

Authors:  F Beermann; S Ruppert; E Hummler; F X Bosch; G Müller; U Rüther; G Schütz
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

View more
  18 in total

1.  Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice.

Authors:  G A Gulliver; R L Herber; A Liem; P F Lambert
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice.

Authors:  Angelika Michel; Annette Kopp-Schneider; Hanswalter Zentgraf; Achim D Gruber; Ethel-Michele de Villiers
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

3.  Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73.

Authors:  Rosita Accardi; Wen Dong; Anouk Smet; Rutao Cui; Agnes Hautefeuille; Anne-Sophie Gabet; Bakary S Sylla; Lutz Gissmann; Pierre Hainaut; Massimo Tommasino
Journal:  EMBO Rep       Date:  2006-01-06       Impact factor: 8.807

4.  Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer.

Authors:  Nicholas C Souders; Duane A Sewell; Zhen-Kun Pan; S Farzana Hussain; Alexander Rodriguez; Anu Wallecha; Yvonne Paterson
Journal:  Cancer Immun       Date:  2007-02-06

Review 5.  Targeting signal transduction for disease therapy.

Authors:  A Levitzki
Journal:  Med Oncol       Date:  1997-06       Impact factor: 3.064

6.  Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene.

Authors:  R Herber; A Liem; H Pitot; P F Lambert
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38.

Authors:  Wen Dong; Ulrich Kloz; Rosita Accardi; Sandra Caldeira; Wei-Min Tong; Zhao-Qi Wang; Lars Jansen; Matthias Dürst; Bakary S Sylla; Lutz Gissmann; Massimo Tommasino
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  Bioluminescent imaging of HPV-positive oral tumor growth and its response to image-guided radiotherapy.

Authors:  Rong Zhong; Matt Pytynia; Charles Pelizzari; Michael Spiotto
Journal:  Cancer Res       Date:  2014-02-13       Impact factor: 12.701

9.  The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding.

Authors:  Rhonda C Kines; Cynthia D Thompson; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

10.  Therapeutic vaccines against human papillomavirus and cervical cancer.

Authors:  Angel Cid-Arregui
Journal:  Open Virol J       Date:  2009-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.